France To Speed Up Patient Access To Unapproved Drugs

France's regulatory agency, ANSM, plans to introduce a faster and more equitable system for access to unapproved medicines for individual patients by streamlining its “temporary use authorization” system.

Accessible
France plans to ease access to unapproved drugs for individual patients. • Source: Shutterstock

More from Market Access

More from Pink Sheet